660 related articles for article (PubMed ID: 24506318)
1. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
[TBL] [Abstract][Full Text] [Related]
2. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
[TBL] [Abstract][Full Text] [Related]
3. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis.
van Vliet E; Dijkema GH; Schuit E; Heida KY; Roos C; van der Post J; Parry EC; McCowan L; Lyell DJ; El-Sayed YY; Carr DB; Clark AL; Mahdy ZA; Uma M; Sayin NC; Varol GF; Mol BW; Oudijk MA
BJOG; 2016 Oct; 123(11):1753-60. PubMed ID: 27550838
[TBL] [Abstract][Full Text] [Related]
5. Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
Roos C; Spaanderman ME; Schuit E; Bloemenkamp KW; Bolte AC; Cornette J; Duvekot JJ; van Eyck J; Franssen MT; de Groot CJ; Kok JH; Kwee A; Merién A; Nij Bijvank B; Opmeer BC; Oudijk MA; van Pampus MG; Papatsonis DN; Porath MM; Scheepers HC; Scherjon SA; Sollie KM; Vijgen SM; Willekes C; Mol BW; van der Post JA; Lotgering FK;
JAMA; 2013 Jan; 309(1):41-7. PubMed ID: 23280223
[TBL] [Abstract][Full Text] [Related]
6. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).
Vis JY; van Baaren GJ; Wilms FF; Oudijk MA; Kwee A; Porath MM; Scheepers HC; Spaanderman ME; Bloemenkamp KW; van Lith JM; Bolte AC; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvank SW; van Eyck J; Franssen MT; Sollie KM; Woiski M; Vandenbussche FP; van der Post JA; Bossuyt PM; Opmeer BC; Mol BW
Am J Perinatol; 2015 Apr; 32(5):451-60. PubMed ID: 25486290
[TBL] [Abstract][Full Text] [Related]
8. Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour.
Naik Gaunekar N; Raman P; Bain E; Crowther CA
Cochrane Database Syst Rev; 2013 Oct; (10):CD004071. PubMed ID: 24173691
[TBL] [Abstract][Full Text] [Related]
9. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
Lorthe E; Kayem G;
BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
[TBL] [Abstract][Full Text] [Related]
10. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
11. Maintenance tocolysis with nifedipine in threatened preterm labour: 2-year follow up of the offspring in the APOSTEL II trial.
van Vliet E; Seinen L; Roos C; Schuit E; Scheepers H; Bloemenkamp K; Duvekot JJ; van Eyck J; Kok JH; Lotgering FK; van Baar A; van Wassenaer-Leemhuis AG; Franssen MT; Porath MM; van der Post J; Franx A; Mol B; Oudijk MA
BJOG; 2016 Jun; 123(7):1107-14. PubMed ID: 26330379
[TBL] [Abstract][Full Text] [Related]
12. Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.
Lange TS; Roos C; Bloemenkamp KW; Bolte AC; Duvekot JJ; Franssen MT; Kok M; Oudijk MA; Porath MM; van der Post JA; Mol BW
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():8-11. PubMed ID: 25596476
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nifedipine and progesterone for maintenance tocolysis after arrested preterm labour.
Kamat S; Veena P; Rani R
J Obstet Gynaecol; 2014 May; 34(4):322-5. PubMed ID: 24483757
[TBL] [Abstract][Full Text] [Related]
14. Single dose 17 alpha-hydroxyprogesterone caproate in preterm labor: a randomized trial.
Tan PC; King AS; Vallikkannu N; Omar SZ
Arch Gynecol Obstet; 2012 Mar; 285(3):585-90. PubMed ID: 21796421
[TBL] [Abstract][Full Text] [Related]
15. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
Roos C; Vis JY; Scheepers HC; Bloemenkamp KW; Duvekot HJ; van Eyck J; de Groot C; Kok JH; Opmeer BC; Oudijk MA; Papatsonis DN; Porath MM; Sollie K; Spaanderman ME; Lotgering FK; van der Post JA; Mol BW
J Matern Fetal Neonatal Med; 2016; 29(10):1556-61. PubMed ID: 26103778
[TBL] [Abstract][Full Text] [Related]
16. A comparative study between nifedipine and isoxsuprine in the suppression of preterm labour.
Raymajhi R; Pratap K
Kathmandu Univ Med J (KUMJ); 2003; 1(2):85-90. PubMed ID: 16388203
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine versus atosiban in the treatment of threatened preterm labour (Assessment of Perinatal Outcome after Specific Tocolysis in Early Labour: APOSTEL III-Trial).
van Vliet EO; Schuit E; Heida KY; Opmeer BC; Kok M; Gyselaers W; Porath MM; Woiski M; Bax CJ; Bloemenkamp KW; Scheepers HC; Jaquemyn Y; van Beek E; Duvekot HJ; Franssen MT; Bijvank BN; Kok JH; Franx A; Mol BW; Oudijk MA
BMC Pregnancy Childbirth; 2014 Mar; 14():93. PubMed ID: 24589124
[TBL] [Abstract][Full Text] [Related]
18. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials.
Berghella V; Saccone G
Am J Obstet Gynecol; 2016 Oct; 215(4):431-8. PubMed ID: 27133012
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
Shennan A; Crawshaw S; Briley A; Hawken J; Seed P; Jones G; Poston L
BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
[TBL] [Abstract][Full Text] [Related]
20. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
